Desktop Metal, backed by a large consortium of corporates, will merge with special purpose acquisition company Trine to list on the NYSE at a $2.5bn valuation.

The Teva, Allianz and Takeda-backed telehealth technology producer has filed to raise up to $100m in an offering that will be boosted by another $100m from Google.

Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.

The Telefónica subsidiary has bought cyber risk consultancy and software producer Govertis having previously invested through subsidiary ElevenPaths.

Alibaba's financial services spinoff has officially filed for a dual listing in Shanghai and Hong Kong that could potentially raise $30bn.

The Sompo, Fujitsu and Relx-backed data miner, which has raised some $2.7bn in venture funding, has chosen the New York Stock Exchange to list its shares.

University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

Gastrointestinal and liver disease-focused Metacrine has filed to go public having raised $125m from investors including Eli Lilly.